The ESR1 mutated metastatic breast cancer diagnostics market is valued at USD 64.61 million in 2025 and is slated to reach USD 92.92 million by 2035, registering a compound annual growth rate (CAGR) of 3.7%. This growth is driven by the increasing prevalence of ESR1 mutations in metastatic breast cancer patients and the rising demand …
Tag Archives: ESR1 Mutated Metastatic Breast Cancer Diagnostics Market
Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Market to Reach USD 89.6 Million by 2034, Growing at a 3.7% CAGR
The global ESR1 mutated metastatic breast cancer diagnostics market is projected to experience steady growth over the next decade. With a year-on-year growth rate of 4.0%, the market size is forecasted to increase from USD 63.4 million in 2024 to USD 89.6 million by 2034. During this period, the demand for diagnostics related to ESR1 …
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Targeting US$ 185 Million by 2033| Future Market Insights,Inc.
The market for ESR1 Mutated Metastatic Breast Cancer Diagnostics was valued at US$ 58.70 million in 2022 and is projected to grow at a CAGR of 11% to reach US$ 185 million from 2023 to 2033. The market for ESR1 mutated metastatic breast cancer diagnostics is expanding as a result of rising breast cancer incidence and the …